NEWSTIER

Thu, Sep 3
Status: JUNE AliveWelcome: Visitordata 16s old

Latest Headlines

848 categorized of 2127
BUSINESS_WIRE18:322m agobullish

A-CAP Announces Agreement to Divest its Interest in Vasco da Gama SAF

A-CAP Announces Agreement to Divest its Interest in Vasco da Gama SAF | Transaction resolves legacy ownership issues, ends related litigation and supports an orderly ownership transition A-CAP continues to effectively manage its asset portfolio and deliver solutions that create tangible benefits fo…
MIDNIGHT_TRADER18:312m agobullish

American Eagle Outfitters Set for Solid Q2 as Aerie Strength Builds, UBS Says

American Eagle Outfitters Set for Solid Q2 as Aerie Strength Builds, UBS Says | 02:31 PM EDT, 09/03/2026 (MT Newswires) -- American Eagle Outfitters (AEO) is poised to deliver a solid fiscal Q2 on continued strength in its Aerie brand and improving trends for the American Eagle label, UBS Securitie…
DOW_JONES18:304m ago

Dow Jones 2:30 PM Averages

Dow Jones 2:30 PM Averages | Dow Jones 2:30 PM Averages Number of Stocks | Index Label | Price | Up/Down | Net Change | Percent Change 30 INDUS 53,692.77 UP 630.82 OR 1.19% 20 TRANSP 20,874.67 UP 161.19 OR 0.78% 15 UTILS 1,083.97 UP 8.49 OR 0.79% 65 STOCKS 16,806.67 UP 173.47 OR 1.04% (END) Dow Jon…
BENZINGA18:295m agobearish

Northland Capital Markets Maintains Outperform on NetApp, Raises Price Target to $187

Northland Capital Markets Maintains Outperform on NetApp, Raises Price Target to $187 | 2:29 PM EDT, September 03, 2026 (Benzinga Newswire) Northland Capital Markets analyst Nehal Chokshi maintains NetApp (NASDAQ:NTAP) with a Outperform and raises the price target from $171 to $187. Write to Benzin…
ANALYST ACTIONS / TARGET/MAINTAINANALYST ACTIONS / UPGRADE
BENZINGA18:295m ago

FDA Says Aware Boston Scientific Issued Letter To Affected Customers Recommending Unused Infinion CX Leads Be Removed From Where They Are Used/Sold; As Of May 27, 2026, Boston Scientific Reported 1,081 Serious Injuries And No Deaths Associated With Issue Related To Infinion CX Leads

FDA Says Aware Boston Scientific Issued Letter To Affected Customers Recommending Unused Infinion CX Leads Be Removed From Where They Are Used/Sold; As Of May 27, 2026, Boston Scientific Reported 1,081 Serious Injuries And No Deaths Associated With Issue Related To Infinion CX Leads | 2:29 PM EDT,…
REGULATORY & CLINICAL / FDA/APPROVAL
BENZINGA18:276m ago

Why Is Cipher Digital Stock Surging Thursday?

Why Is Cipher Digital Stock Surging Thursday? | 2:27 PM EDT, September 03, 2026 (Benzinga Newswire) Cipher Digital Inc. (NASDAQ:CIFR) stock traded higher Thursday as crypto-linked assets gained momentum. Comments from Federal Reserve Gov. Christopher Waller may have added to the risk-on sentiment.…
BENZINGA18:277m ago

Walmart Stock Gains on Broad Market Rally and New Delivery Partnership

Walmart Stock Gains on Broad Market Rally and New Delivery Partnership | 2:27 PM EDT, September 03, 2026 (Benzinga Newswire) Shares of Walmart Inc. (NASDAQ:WMT) are trading higher Thursday afternoon as the retail giant benefits from broader market tailwinds and fresh expansion within its delivery e…
MIDNIGHT_TRADER18:267m agobullish

Top Midday Decliners

Top Midday Decliners | 02:26 PM EDT, 09/03/2026 (MT Newswires) -- Ultragenyx Pharmaceutical (RARE) said late Wednesday a phase 3 study of apazunersen in Angelman syndrome did not meet its primary endpoint nor a key secondary endpoint. Shares slumped 45% as intraday trading volume catapulted to over…
BENZINGA18:258m ago

Raymond James Maintains Outperform on Haemonetics, Raises Price Target to $125

Raymond James Maintains Outperform on Haemonetics, Raises Price Target to $125 | 2:25 PM EDT, September 03, 2026 (Benzinga Newswire) Raymond James analyst Andrew Cooper maintains Haemonetics (NYSE:HAE) with a Outperform and raises the price target from $105 to $125. Write to Benzinga at editorial@b…
ANALYST ACTIONS / TARGET/MAINTAINANALYST ACTIONS / UPGRADE
BENZINGA18:259m agobullish

Aptevo Therapeutics Reports 93% Clinical Benefit Rate in Key Leukemia Trial

Aptevo Therapeutics Reports 93% Clinical Benefit Rate in Key Leukemia Trial | 2:25 PM EDT, September 03, 2026 (Benzinga Newswire) Aptevo Therapeutics Inc. (NASDAQ:APVO) announced that its lead candidate mipletamig achieved a 93% clinical benefit rate when administered as a triplet therapy to frontl…
BENZINGA18:249m agobearish

Raymond James Maintains Outperform on Snowflake, Raises Price Target to $425

Raymond James Maintains Outperform on Snowflake, Raises Price Target to $425 | 2:24 PM EDT, September 03, 2026 (Benzinga Newswire) Raymond James analyst Adam Tindle maintains Snowflake (NYSE:SNOW) with a Outperform and raises the price target from $275 to $425. Write to Benzinga at editorial@benzin…
ANALYST ACTIONS / TARGET/MAINTAINANALYST ACTIONS / UPGRADE
DOW_JONES18:2410m agobullish

MW New doubts emerge about whether Fed will raise interest rates this month

MW New doubts emerge about whether Fed will raise interest rates this month | While top Fed officials disagree on outlook, data over the next 10 days will be closely watched After Federal Reserve Chairman Kevin Warsh spoke last week from Jackson Hole, Wyo., markets were pretty convinced that the ce…
MACRO & CENTRAL BANKS / FED/RATES
BENZINGA18:2311m agobullish

Palantir’s Alex Karp: The Real AI Leak Isn't Data, It's Your 'Alpha'

Palantir’s Alex Karp: The Real AI Leak Isn't Data, It's Your 'Alpha' | 2:23 PM EDT, September 03, 2026 (Benzinga Newswire) Companies have long worried about artificial intelligence exposing sensitive data. Palantir Technologies Inc. (NASDAQ:PLTR) CEO Alex Karp says they’re focused on the wrong thre…
BENZINGA18:2212m ago

Raymond James Maintains Outperform on CrowdStrike Holdings, Raises Price Target to $250

Raymond James Maintains Outperform on CrowdStrike Holdings, Raises Price Target to $250 | 2:22 PM EDT, September 03, 2026 (Benzinga Newswire) Raymond James analyst Adam Tindle maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Outperform and raises the price target from $240 to $250. Write to Benz…
ANALYST ACTIONS / TARGET/MAINTAINANALYST ACTIONS / UPGRADE
DOW_JONES18:2212m ago

NYSE New 52-Week Highs And Lows

NYSE New 52-Week Highs And Lows | New Highs 76 COMPANY SYMBOL HIGH VOLUME ------- ------ ---- ------ Adams Natural Rscs Fd PEO 29.53 33,583 Algonquin Pwr Nts 2079 AQNB 26.31 10,447 Andersen Group ANDG 57.45 75,103 ArcelorMittal ADR MT 76.72 1,065,477 Ategrity Spec Insurance ASIC 27.59 21,863 Banco…
DOW_JONES18:2212m ago

NYSE American New 52-Week Highs And Lows

NYSE American New 52-Week Highs And Lows | New Highs 3 COMPANY SYMBOL HIGH VOLUME ------- ------ ---- ------ CompX IntlA CIX 36.12 10,763 Pinnacle Acquisition PNAQ.U 10.02 277 Riley Exploration Permn REPX 41.89 186,282 New Lows 9 COMPANY SYMBOL LOW VOLUME ------- ------ ---- ------ Apimeds Pharma U…
BENZINGA18:2113m agobearish

Raymond James Maintains Outperform on Broadcom, Raises Price Target to $475

Raymond James Maintains Outperform on Broadcom, Raises Price Target to $475 | 2:21 PM EDT, September 03, 2026 (Benzinga Newswire) Raymond James analyst Srini Pajjuri maintains Broadcom (NASDAQ:AVGO) with a Outperform and raises the price target from $450 to $475. Write to Benzinga at editorial@benz…
ANALYST ACTIONS / TARGET/MAINTAINANALYST ACTIONS / UPGRADE
BENZINGA18:1914m agobearish

Raymond James Maintains Outperform on Hewlett Packard, Raises Price Target to $86

Raymond James Maintains Outperform on Hewlett Packard, Raises Price Target to $86 | 2:19 PM EDT, September 03, 2026 (Benzinga Newswire) Raymond James analyst Simon Leopold maintains Hewlett Packard (NYSE:HPE) with a Outperform and raises the price target from $74 to $86. Write to Benzinga at editor…
ANALYST ACTIONS / TARGET/MAINTAINANALYST ACTIONS / UPGRADE